Background: The design of novel nanoparticles with higher therapeutic efficacy and lower side effects, is still difficult but encouraging in cancer therapy. Specifically, for upconversion nanoparticles (UCNP)-based drug release, a high intensity of NIR light (1.4~5.0 W/cm 2 )
Introduction
Chemotherapy (Chemo) is an important/extensive method applied nowadays in clinical cancer therapy. The success of Chemo requires the precise delivery of anticancer drugs to cancerous cells and to avoid the killing of normal cells.
1,2 Therefore, various drug releases based on such stimuli as pH, 3, 4 ultrasonic, 5 light, 6, 7 and glutathione 8, 9 have been developed. Among these stimuli, light exhibits obvious advantages over the others, which can afford drug release both spatially and temporally, owning to its excellent merits of input intensity and tunable wavelength.
penetration depth to a few microns, thus limiting their potential use in practical application. Compared to UV/Vis light, near-infrared (NIR) light (700~1100 nm) is at the biological window with significantly deeper tissue penetration, weak background fluorescence, and a negligible irradiation damage. 12 Unfortunately, unlike UV/Vis lights, the energy of NIR light is insufficient to trigger a photochemical reaction, on which drug release is based. 13 Upconverting nanoparticles (UCNP), 14 which can absorb NIR light and convert it into high energy UV or Vis lights, have therefore been employed as photo-transducers to open the door for the development of NIR-based drug release. 15 For example, Cui et al 13 24 according to the American National Standard for Safe Use of Lasers, have been popularly used for the NIR-responsive drug release 13, [16] [17] [18] [19] [20] [21] [22] [23] (see Table S1 ). The employed high intensity of NIR light irradiation well above MPE will certainly lead to overheating and/or photodamage of skin, 24 which should be a fundamental challenge for the NIR-responsive chemotherapy. In a pioneering work to address the challenge, He et al 22 recently reported NIR-induced drug release at an ultralow intensity of 0.35 W/cm 2 . Few studies have been reported so far to the best of our knowledge.
To enable drug release to be triggered upon NIR light irradiation at an ultralow-intensity below MPE, in this work we first prepared one of the most efficient UCNPs (NaYF 4 :Yb, Tm@NaYF 4 ) 18 known to date. On the other hand, the bonddissociation energies (E BD ) of three known photocleavable linkers including 2-nitrobenzyl, 13, 20 coumarin, 25, 26 and thioether (-S-BP) 27 were calculated based on density functional theory (DFT), and the -S-BP linker with the lowest E BD is selected assuming that it can be photocleaved upon a relative low intensity NIR light irradiation to trigger drug release. Finally, the thioether linker is capable of associating with β-cyclodextrin (β-CD), 28 and β-CD has been popularly used as a 'gatekeeper' to block pore openings and prevent drug from pre-releasing. 29 As displayed in Scheme 1A, the highly emissive UCNP is first synthesized. The UCNP is then coated with MS shell (UCMS). Furthermore, the surface of UCMS is modified with the -S-BP linker, leading to UCMS-S-BP nanoparticles. Finally, after drug Dox is loaded into the UCMS's pore channels, the pore openings are blocked through the association of -S-BP linker with β-CD (UCMS(Dox)-S-BP@β-CD). Scheme 1B shows the on-demand Dox release upon 980 nm NIR light irradiation with an ultralow intensity below MPE used, during which the upconverted UV light from UCNP cleaves the -S-BP linker leading to the disscoation of β-CD gatekeepers trigger on-demand Dox release. 
Experimental Materials

Characterization
Transmission electron microscopy (TEM) images were captured by the JEM-1400 (JEOL). UV-Vis measurement was carried out using a Cary50 UV-Vis spectrophotometer (Varian). N 2 adsorption-desorption isotherms were measured by a Micromeritics Tristar 3,000 accelerated surface area and pore size analyzer. Upconversion luminescence properties were measured in Northeast Normal University. X-ray powder diffraction (XRD) patterns were recorded by a German BRUKER D8-ADVANCE. Fluorescence microscopy images were captured by Olympus' fluorescence microscope (Japan).
Computational details of DFT
The DFT calculation was performed using the Gaussian 09 program package. 30 All the geometry optimizations were made in gas phase with Becke's three-parameter functional combined with Lee et al's correlation functional (B3LYP) 31 and 6-31+g(d,p) 32 basis sets. Furthermore, we employed the counterpoise corrections to account for basis set superposition error (BSSE). 33, 34 The ball-andstick structures of three linker molecules including thioether, coumarin and 2-nitrobenzyl (see Figure S1 ) were built and optimized based on Gaussian 09 program package. The E BD of a molecule AB was calculated (see Table 1 ) by Gaussian 09 program package from the following equation:
where E AB, E A , E B , and E BSSE are the total energy of the molecule AB, the energies of two separate fragments A and B, and error energy respectively (see Table S2 ). The optimized atomic coordinates of the three linker molecules are shown in Tables S3, S4 and S5, respectively.
Laser intensity measurement
The 980 nm laser intensities were measured by Thorlabs PM100D laser power meter (Thorlabs Company, Newton, NJ, USA). A fixed distance of 3 cm was set between the laser source and laser power meter. The laser intensities were recorded at different laser powers ranging from 0.10 to 2.5 W. The detailed results were given in Figure S2 . were added to a three necked flask (250 mL) containing OA (24 mL) and ODE (60 mL). The solution was heated to 160°C and kept 3 hours under argon flow and magnetic stirring. The temperature was then cooled to 50°C, and 40 mL of methanol containing NH 4 F (16 mmol, 592.6 mg) and NaOH (10 mmol, 400.0 mg) was added. The mixture was stirred for another 30 minutes and heated to 100°C to evaporate the methanol and then heated to 300°C and kept 1 hour under argon protection. After it was cooled to room temperature, the product was collected by centrifugation and washed three times with ethanol/cyclohexane, and finally re-dispersed in cyclohexane (40 mL) for further use. For the synthesis of NaYF 4 :Yb,Tm@NaYF 4 nanoparticles, YCl 3 ·6H 2 O (1.00 mmol, 303.4 mg), and pre-prepared NaYF 4 :Yb,Tm (2.00 mmol, 20 mL) were added to a three necked flask having OA (12 mL) and ODE (30 mL). The solution was heated to 160°C and kept for 3 hours under argon protection. After the temperature was cooled to 50°C, 20 mL of methanol containing of NH 4 F (4 mmol, 148.1 mg) and NaOH (2.5 mmol, 100.0 mg) was added and the mixture was stirred for another 30 minutes. Subsequently, the solution was heated to 100°C to evaporate the methanol and then heated to 300°C and kept for 1.5 hours under argon protection. The final product was dispersed in cyclohexane (20 mL) for further use.
Synthesis of
Synthesis of MS-coated UCNP (UCMS)
The UCMS were prepared by coating UCNP with MS based on a previously reported method. 35 Briefly, the above UCNP (660 uL) in cyclohexane were added to a flask containing distilled water (20 mL) and CTAB (200 mg). The mixture was heated to 80°C and kept 30 minutes to remove cyclohexane. Then, NaOH solution (200 uL, 0.1 M) and distilled water (20 mL) were added. After 30 minutes of sonication, ethanol (2 mL) and TEOS (400 μL) were slowly added using a peristaltic pump (BT100-2J) and the mixture was stirred at 35°C for 24 hours. The nanoparticles were isolated via centrifugation (10,000 rpm, 10 minutes), washed with ethanol, and dried in a vacuum over overnight.
Synthesis of UCMS-S-BP nanoparticles
At first, the UCMS-SH nanoparticles were prepared as described in the literature, 36 except that the MS nanoparticles were replaced by UCMS. The UCMS (200 mg) and MPTMS (440 μL) were dispersed in absolute ethyl alcohol (16 mL) and sonicated for 30 minutes. The solution was stirred for 24 hours at room temperature. The resulting nanoparticles were then centrifuged (10,000 rpm, 10 minutes), washed twice with ethanol and dried under vacuum. The UCMS-S-BP nanoparticles were prepared as described in the literature 37 with an improvement. In a 50 mL round-bottomed flask, the UCMS-SH nanoparticles (200 mg) were re-dispersed in DMF (10 mL) and sonicated for about 30 minutes. The BP (10 mg) and anhydrous K 2 CO 3 (20 mg) were then added and the contents of the flask were stirred for 24 hours. After that, the products were isolated and extracted for 6 hours with NaCl (1%) in methanol to remove CTAB. The resulting UCMS-S-BP nanoparticles were collected by centrifugation (10,000 rpm, 10 minutes), washed five times with distilled water and ethanol, and dried in a vacuum.
Synthesis of FITC-UCMS-S-BP nanoparticles
The FITC-UCMS-S-BP nanoparticles were prepared as described in the literature 38 with a modification. In a 50 mL round-bottomed flask, the UCMS-S-BP nanoparticles (50 mg) were re-dispersed in ethanol (10 mL) and sonicated for about 30 minutes. Then, the APTES (30 μL) was added. The contents of the flask were stirred for another 24 hours at ambient temperature. The nanoparticles were collected by centrifugation (10,000 rpm, 10 minutes), and washed two times with DMF. The obtained nanoparticles re-dispersed in DMF and FITC (0.5 mg) were added. After 24 hours reaction, the final FITC-UCMS-S-BP nanoparticles were centrifuged (10,000 rpm, 10 minutes), washed with ethanol five times, and dried in a vacuum oven.
Loading and releasing of drug
UCMS-S-BP nanoparticles (50 mg) were first added in Dox aqueous solution (1 mg/mL, 5 mL), and treated by ultrasonic cleaner for 30 minutes. After the solution was stirred for 24 hours at room temperature, β-CD (500 mg) was added and stirred for another 24 hours. The resulting UCMS(Dox)-S-BP@β-CD nanoparticles were obtained by centrifugation (10,000 rpm, 10 minutes), and dried in a vacuum. The Dox loading efficiency was calculated to be about 3.12% (31.2 μg Dox in 1 mg UCMS-S-BP, Figure S3 ). Photo-triggered Dox release experiment was done in the cuvette under dark conditions. The nanoparticles were put at the corner of a cuvette and irradiated by 980 nm NIR light at different intensities. The amount of Dox released in supernatant solutions (interval 10 minutes) was determined by UV-Vis spectrometer. The control samples were kept in the dark without laser irradiation. were seeded and incubated in 6-well cell culture cluster for 24 hours. Then, the cell medium was replaced by DMEM supplemented with FITC-UCMS-S-BP (100 µg/mL). After 4 hours incubation, the residual nanoparticles were rinsed by phosphate buffered saline (PBS). Next, the cells were fixated by formalin about 10 minutes. After that the cell nucleus were stained by Hoechst 33,258 about 30 minutes. The cell uptake images of FITC-UCMS-S-BP were observed by using a fluorescence microscope (Olympus, Japan).
Cell culture and uptake
Cytotoxicity of UCMS(Dox)-S-BP@β-CD nanoparticles
In vitro cytotoxicity was examined using the standard CCK-8 assay. HeLa cells (1×10 4 ) and then incubated for 24 hours. The CCK-8 (10 μL) was added to the medium and cultured for another 2.5 hours. The microplate reader (WD-2102A) was used to test the absorbance of each well at 450 nm wavelength. The inhibition rates of cell growth were calculated by the following formula:
where the absorbance value of blank sample A 0 , control sample A 1 and treatment sample A 2 are obtained from the microplate reader (WD-2102A). The cell experiments 100 nm 100 nm 100 nm were run three replicates in each concentration group and repeated three times.
Statistical analysis
The statistical data were shown as Mean ± SD unless otherwise noted. The statistical significance of data was tested by the T.TEST in the Microsoft Excel and a value of P<0.05 was considered statistically significant.
Results and discussion
Structure characterization and fluorescent measurement
As a starting point of our study, NaYF 4 :Yb/Tm and NaYF 4 : Yb/Tm@NaYF 4 nanoparticles were subsequently synthesized using a recently reported method 22 given that the resulting NaYF 4 :Yb/Tm@NaYF 4 is known to be one of the most efficient UCNP. TEM images ( Figure 1A and B) show they are monodispersed and uniform in size with an average diameter of 34.6±1.9 nm and 39.8±1.7 ( Figure S4 ), respectively. The as-prepared UCNP (NaYF 4 :Yb/ Tm@NaYF 4 ) was then coated with a MS shell denoted as UCMS and the corresponding TEM image ( Figure 1C) shows they have core-shell structure with an average diameter of 80.3±4.7 nm. Figure 1D shows the XRD analysis of the above-mentioned nanoparticles. It can be seen they are well-indexed as hexagonal NaYF 4 (all XRD peaks are in accordance with the JCPDS 16-0334 pattern) and highly crystallized which is in favor of photo-triggered biomedical application. 39 A distinct diffraction heave (2θ=22.5°) is also observed for UCMS, suggesting an amorphous MS shell is formed 13 in agreement with the previous TEM observation. Figure 1E is the nitrogen adsorption-desorption measurement of the UCMS nanoparticles, which shows the pore diameter and surface area are 3.2 nm and 301 m 2 /g respectively. The fluorescent spectra measurement showed the upconversion emission intensity of UCNP is 16-fold stronger than that of naked NaYF 4 ( Figure 1F ) indicating it is highly emissive. It is therefore expected that the laser intensity required to cleave photosensitive linker and trigger drug release can be significantly reduced.
Linker selection and modification
Moreover, we also perform theoretical calculation to select a photocleavable linker with relatively low E BD and expect that the intensity of NIR light for linker cleavage could be further reduced. The E BD of three linker candidates including 2-nitrobenzyl, coumarin, and thioether were calculated for comparison and the results are listed in Table 1 . It can be seen the E BD of thioether linker (−271.2 KJ/mol) is 32% lower than that of the two others (−402.8 KJ/mol and −397.2 KJ/mol). Therefore, the thioether linker with the lowest E BD , capability of associating gatekeeper β-CD, and novelty of first employment in drug release application, was selected.
The procedure for the functionalization of UCMS nanoparticles with -S-BP linker is illustrated in Figure S5 and checked by UV-Vis spectra, fluorescence emission spectra, and thermal gravimetric analysis (TGA) as shown in Figure 2 . It can be seen in Figure 2A that a new absorption peak at 260 nm, which can be attributed to biphenyl portion of the -S-BP linker, is observed for the UCMS-S-BP sample in comparison with no peak observed for the UCMS sample, indicating that the -S-BP linker is successfully anchored on the MS surface. Figure 2B shows the fluorescence emission spectra of UCMS-S-BP@β-CD, UCMS-S-BP, and UCMS respectively. By comparing with UCMS showing no emission peak, the individual emission of UCMS-S-BP at 320 nm indicates that the thioether linker is successfully grafted on the surface of UCMS nanoparticles. After association of thioether linker with β-CD via host/guest interaction (β-CD capping), a further increase in intensity at 320 nm for UCMS-S-BP@β-CD is observed in agreement with the literature 40 which demonstrates a successful modification of -S-BP linker and its capability of β-CD capping. TGA measurements ( Figure  2C ) also showed an obvious decrease in weight of the stepwise functionalized nanoparticles, indicating a successful surface functionalization and β-CD capping.
Drug release performance
The NIR light triggered drug release behaviors of UCMS (Dox)-S-BP@β-CD nanoparticles upon NIR light irradiation at different low intensities were investigated by monitoring the change in Dox concentration with UV-Vis absorption spectroscopy. Figure 3 shows only a small amount of Dox (4.8%) is released for the control sample in 120 minutes without NIR irradiation (curve a), suggesting a satisfactory β-CD gatekeeper efficiency for our system. In contrast, Figure 3 (curves b-d). To meet the requirement of MPE, the excited laser intensity of 0.30 W/cm 2 was chosen as the optimum condition in the following study. The NIR light-induced cleavage of the thioether linker was also confirmed by the UV-Vis absorption spectra for a peak intensity at 260 nm, which corresponds to the cleaved biphenyl fragments of thioether linker, increases with increasing irradiation time ( Figure S6 ). Overall, all the above results indicated ultralow-intensity NIR light triggered on-demand drug release from UCMS(Dox)-S-BP@β-CD can be realized, in which 0.30 W/cm 2 laser intensity is lower than MPE.
Photodamage effects
The photodamage effects were investigated upon 980 nm laser irradiation with 0.30 and 2.0 W/cm 2 , respectively. The NIR light-induced photothermal effects were first measured by exposure of 2 mL water in the cuvette 21 to the laser and the results are shown in Figure 4A . It can be seen that the temperature increases with increasing irradiation time due to the high absorbance of water to 980 nm laser ( Figure S7 
In vitro cell uptake and cytotoxic effects
Cell uptake and cytotoxicity of UCMS(Dox)-S-BP@β-CD nanoparticles were first evaluated before in in-vitro experiments. For testing cell uptake, the cell nucleus were labeled by Hoechst 33,258 dye, which can combine with DNA double strands and show a bright blue fluorescence. FITC with green fluorescence was used to stain nanoparticles. 38 As shown in Figure 5A , the green fluorescence is found inside HeLa cells and mainly around the blue nuclei region, indicating the effective HeLa cell uptake of nanoparticles through either endocytosis or micropinocytosis. 8 For cytotoxicity experiment, the influence of concentration on HeLa cells viability was evaluated by CCK-8 assay. Incubation of HeLa cells with UCMS-S-BP@β-CD or the Dox loaded nanocarriers (UCMS(Dox)-S-BP@β-CD) do not cause a cell death without light irradiation ( Figure 5B ), indicating the loading Dox was not released form UCMS(Dox)-S-BP@β-CD in agreement with the results in Figure 3 . In addition, there is also no significant cell death in the UCMS-S-BP@β-CD-treated group (95.3±2.3%) upon 980 nm irradiation, confirming the upconverted UV light can be safely used in vitro.
To verify the therapeutic effect of the UCMS(Dox)-S-BP@β-CD under ultralow intensity NIR light irradiation, the cytotoxicity was systematically evaluated by incubating HeLa cells with UCMS(Dox)-S-BP@β-CD at various concentrations. In comparison with the control sample without laser irradiation (Figure 5B ), the cell viabilities upon irradiation shown in Figure 6A are significantly lower, demonstrating the cell death is caused by the released Dox from UCMS(Dox)-S-BP@β-CD. In addition, the viabilities of cells are strongly dependent on not only the nanoparticle's concentration but also irradiation time. Specifically, when the laser irradiation time increasing from 5 to 20 minutes at the maximum concentration of 500 μg/mL, the cell viabilities decrease significantly from 52.2% to 14.8%. It should be noted that a strategy of NIR light irradiation with short interval (ie,1~2.5 min) was adopted in the previous literature 18, 41, 42 to avoid photodamage when the high laser intensity was employed, and that according to the American National Standard for Safe Use of Laser, the intermittent exposure limit of 10 seconds is suggested for laser intensity over MPE. 24 Our ultralow intensity irradiation below MPE addresses the problem fundamentally with few restrictions on the irradiation time. The ultralow intensity irradiation can therefore make full use of its advantage both spatially and temporally to achieve the best therapeutic effect without side effects. Moreover, the fluorescence live/dead cell staining displayed similar results with the above CCK-8 assay. It can be seen in Figure 6B , HeLa cells cultured with UCMS (Dox)-S-BP@β-CD without light irradiation induced little HeLa cell death. Exposure to 980 nm laser, the mortality of HeLa cells increased with the increasing irradiation time significantly.
Conclusion
In summary, we have demonstrated a novel approach to enable ultralow-intensity NIR light triggered on-demand drug release to avoid the potential photodamage on healthy neighbor cells by employing highly emissive UCNP together with photocleavable linker with low bond dissociation energy. It was found that the selected thioether linker based on DFT calculation is cleavable for drug releasing under 980 nm NIR light irradiation with an ultralow laser intensity of 0.30 W/cm 2 , which is among the lowest reported values and below the MPE of skin (0.33 W/ cm 2 ). In vitro experiments show that about 85.2% of HeLa cells were killed within 20 minutes irradiation. We hope the preliminary results may shed light on developing future safe photochemistry-based drug delivery systems with higher therapeutic efficiency and lower side effects.
